Back to search
FDAFDA · Food and drugs·Recall number Z-0085-2023

Prismaflex HF20 Set (product code 109841). For use in providing continuous fluid management and renal replacement therapies.

Published October 19, 2022 · Recall initiated: September 14, 2022

Summary

FDA records medical device Class II recall Z-0085-2023, published October 19, 2022 and initiated September 14, 2022. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 29,764 devices; Lot: UDI 07332414089443, All Lot Codes. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Within the current Prismaflex set IFU (instructions for use), there is a mistranslation of the Extonian (Eesti) text. The mistranslation indicates contradictory information related to the patient body weight restrictions.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
US Nationwide
Lot
UDI 07332414089443, All Lot Codes
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Prismaflex HF20 Set (product code 109841). For use in providing continuous fluid management and renal replacement therapies. recalled?

Yes. FDA published recall Z-0085-2023 on October 19, 2022. Reported hazard: Within the current Prismaflex set IFU (instructions for use), there is a mistranslation of the Extonian (Eesti) text. The mistranslation indicates contradictory information related to the patient body weight restrictions.

What should I do if I have this product?

Voluntary: Firm initiated · Letter